Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)
Hong Kong · Delayed Price · Currency is HKD 5.50
+0.05 (0.92%)
At close: Mar 27, 2026
HKG:6922 Revenue
In the year 2025, Cryofocus Medtech (Shanghai) had annual revenue of 95.27M CNY with 77.97% growth. Cryofocus Medtech (Shanghai) had revenue of 51.11M in the half year ending June 30, 2025, with 170.20% growth.
Revenue
95.27M CNY
Revenue Growth
+77.97%
P/S Ratio
12.70
Revenue / Employee
529.27K CNY
Employees
180
Market Cap
1.35B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 95.27M | 41.74M | 77.97% |
| Dec 31, 2024 | 53.53M | 12.58M | 30.72% |
| Dec 31, 2023 | 40.95M | 13.80M | 50.83% |
| Dec 31, 2022 | 27.15M | 4.72M | 21.06% |
| Dec 31, 2021 | 22.43M | 13.37M | 147.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sisram Medical | 2.84B |
| Gaush Meditech | 1.54B |
| Vincent Medical Holdings | 932.78M |
| Acotec Scientific Holdings | 717.35M |
| MicroTech Medical (Hangzhou) | 482.95M |
| Venus Medtech (Hangzhou) | 468.17M |
| Shanghai HeartCare Medical Technology Corporation | 454.34M |
| MicroPort CardioFlow Medtech | 402.73M |